IDEXX Labs Earnings, Revenue Beat in Q1 By

© Reuters. IDEXX Labs Earnings, Revenue Beat in Q1 – IDEXX Labs (NASDAQ:) reported on Tuesday first quarter that beat analysts’ forecasts and revenue that topped expectations.

IDEXX Labs announced earnings per share of 2.09 on revenue of 777.7M. Analysts polled by anticipated EPS of 1.71 on revenue of 738.43M.

IDEXX Labs shares are up 10% from the beginning of the year, still down 4.20% from its 52 week high of 573.98 set on February 18. They are under-performing the S&P 500 which is up 11.62% from the start of the year.

IDEXX Labs follows other major Consumer/Non-Cyclical sector earnings this month

IDEXX Labs’s report follows an earnings beat by Procter&Gamble on April 20, who reported EPS of 1.26 on revenue of 18.11B, compared to forecasts EPS of 1.19 on revenue of 17.96B.

Coca-Cola had beat expectations on April 19 with first quarter EPS of 0.55 on revenue of 9B, compared to forecast for EPS of 0.5039 on revenue of 8.68B.

Stay up-to-date on all of the upcoming earnings reports by visiting’s earnings calendar

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Most Related Links :
Business News Governmental News Finance News

Source link

Back to top button